mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NC_000913_3_bme_pgi | 526,792 | 0 | A | C | 34.0% | 53.0 / 42.1 | 54 | S1178R (AGC→CGC) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 526,796 | 0 | C | G | 34.0% | 75.7 / 45.3 | 53 | A1179G (GCG→GGG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 526,800 | 0 | A | G | 27.7% | 73.3 / 27.9 | 48 | E1180E (GAA→GAG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 4,296,061 | 0 | C | T | 21.3% | 103.3 / 26.9 | 61 | intergenic (+266/+376) | gltP/yjcO | glutamate/aspartate:proton symporter/Sel1 family TPR‑like repeat protein |
| Marginal new junction evidence (lowest skew 10 of 131 shown) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NC_000913_3_bme_pgi | = 2412638 | 24 (0.670) | 6 (0.180) | 6/262 | 3.6 | 20.6% | intergenic (‑44/+39) | yfbU/yfbV | UPF0304 family protein/UPF0208 family inner membrane protein |
| ? | NC_000913_3_bme_pgi | = 2412645 | 24 (0.720) | intergenic (‑51/+32) | yfbU/yfbV | UPF0304 family protein/UPF0208 family inner membrane protein | |||||
| * | ? | NC_000913_3_bme_pgi | 4296208 = | NA (NA) | 6 (0.180) | 6/268 | 3.7 | 17.4% | noncoding (373/600 nt) | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites |
| ? | NC_000913_3_bme_pgi | 4296399 = | 30 (0.840) | noncoding (564/600 nt) | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites | |||||
| * | ? | NC_000913_3_bme_pgi | = 1097454 | 6 (0.170) | 6 (0.170) | 6/282 | 3.9 | 50.0% | intergenic (+625/+111) | ycdU/serX | putative inner membrane protein/tRNA‑Ser |
| ? | NC_000913_3_bme_pgi | = 1097476 | NA (NA) | intergenic (+647/+89) | ycdU/serX | putative inner membrane protein/tRNA‑Ser | |||||
| * | ? | NC_000913_3_bme_pgi | = 1097295 | 12 (0.330) | 6 (0.170) | 6/282 | 3.9 | 40.0% | intergenic (+466/+270) | ycdU/serX | putative inner membrane protein/tRNA‑Ser |
| ? | NC_000913_3_bme_pgi | = 1097454 | 6 (0.170) | intergenic (+625/+111) | ycdU/serX | putative inner membrane protein/tRNA‑Ser | |||||
| * | ? | NC_000913_3_bme_pgi | = 1097092 | 25 (0.700) | 6 (0.170) | 6/282 | 3.9 | 24.5% | intergenic (+263/+473) | ycdU/serX | putative inner membrane protein/tRNA‑Ser |
| ? | NC_000913_3_bme_pgi | = 1097295 | 12 (0.330) | intergenic (+466/+270) | ycdU/serX | putative inner membrane protein/tRNA‑Ser | |||||
| * | ? | NC_000913_3_bme_pgi | = 1097092 | 25 (0.700) | 6 (0.170) | 6/282 | 3.9 | 19.4% | intergenic (+263/+473) | ycdU/serX | putative inner membrane protein/tRNA‑Ser |
| ? | NC_000913_3_bme_pgi | = 1097114 | NA (NA) | intergenic (+285/+451) | ycdU/serX | putative inner membrane protein/tRNA‑Ser | |||||
| * | ? | NC_000913_3_bme_pgi | 4295975 = | 43 (1.200) | 5 (0.150) | 5/268 | 4.1 | 12.4% | noncoding (140/600 nt) | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites |
| ? | NC_000913_3_bme_pgi | 4296406 = | 30 (0.880) | noncoding (571/600 nt) | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites | |||||
| * | ? | NC_000913_3_bme_pgi | 4295975 = | 43 (1.200) | 5 (0.150) | 5/268 | 4.1 | 10.9% | noncoding (140/600 nt) | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites |
| ? | NC_000913_3_bme_pgi | 4296069 = | NA (NA) | noncoding (234/600 nt) | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites | |||||
| * | ? | NC_000913_3_bme_pgi | 4295836 = | NA (NA) | 5 (0.150) | 5/268 | 4.1 | NA | noncoding (1/600 nt) | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites |
| ? | NC_000913_3_bme_pgi | 4295869 = | NA (NA) | noncoding (34/600 nt) | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites | RIP321 (repetitive extragenic palindromic) element; contains 11 REP sequences and 4 IHF sites | |||||
| * | ? | NC_000913_3_bme_pgi | 4280509 = | 30 (0.840) | 5 (0.150) | 5/268 | 4.1 | 15.8% | coding (529/1650 nt) | yjcE | putative cation/proton antiporter |
| ? | NC_000913_3_bme_pgi | 4280529 = | 25 (0.730) | coding (549/1650 nt) | yjcE | putative cation/proton antiporter | |||||